NL-OMON39397
Completed
Not Applicable
Dynamics of tumour hypoxia and metabolism during Chemoradiotherapy for stage III Non Small Cell Lung Cancer, using 18F-FAZA-PET/CT and 18F-FDG-PET/CT. A Pilot Study - Tumour hypoxia and tumour metabolism during Chemoradiotherapy.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- non-small-cell-lung-cancer
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 10
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- WHO PS 0\-2
- •\- Histological or cytological confirmation of non\-small cell lung cancer.
- •\- Stage IIIA or IIIB
- •\- Adequate pulmonary function estimated by flow volume curves
- •\- Life expectancy of at least 6 months
- •\- Planned for 25 x 2\.4 Gy 3DCRT, with concomitant chemotherapy
Exclusion Criteria
- •\- Other stages than stage III NSCLC
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serumCancers of different originC30-C39Malignant neoplasms of respiratory and intrathoracic organsDRKS00006297Klinik für Radio-OnkologieUniversitätsSpital Zürich300
Not yet recruiting
Not Applicable
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000041659Saitama Medical University International Medical Center20
Completed
Not Applicable
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CThoofd hals kankerHypoxia in locally advanced Head and Neck cancer10027656NL-OMON36574niversitair Medisch Centrum Groningen20
Active, not recruiting
Phase 1
The change in PET and MRI measurements over time as a predictor for metastatic colorectal cancer outcome.Advanced colorectal cancer, refractory to all available medicationsMedDRA version: 18.1Level: PTClassification code 10010035Term: Colorectal cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-006280-21-BEJules Bordet Institute53
Active, not recruiting
Not Applicable
Imagerie fonctionnelle de l'hypoxie du cancer du col utérin par 18F-FETNIM TEP/TDMQuantification du degré d'hypoxie par mesure de la fixation du 18F-FETNIM par TEP/TDM avant traitement radio-chimiothérapeutique et après le prélèvement histologique.EUCTR2006-005564-12-FRaboratoire IASO